Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedi ...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
L'Oréal to acquire a 10% stake in Galderma recognizing its dermatology category leadership and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR ZUG,... Ad hoc announcement ...
Dr. Kiana Aran was selected for her achievements in the field of bioengineering. Aran is investigating the use of fingertip sensors for viral detection, exploring how artificial intelligence can ...
1 Nemluvio was granted Breakthrough Therapy Designation in December 2019 and Priority Review in February 2024 by the U.S. FDA – a status reserved for medicines with the potential to ...
Amidst this rapidly evolving landscape, white label AI tools have become pivotal for companies seeking to harness the power of AI without the extensive resources typically required for developing such ...
In December, the FDA approved Nemluvio (nemolizumab) in combination with topical corticosteroids and/or calcineurin inhibitors for the treatment of adults and pediatric patients 12 years of age and ...
Galderma adds new indication for blockbuster hope Nemluvio Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to its label. Sales & Marketing ...
If you're planning to sell textile products in the EU, they must comply with EU labelling requirements. In general, they must carry a label clearly identifying the composition of all textile fibres ...
Business Wire IndiaOrganised by the Hong Kong Trade Development Council (HKTDC), the 41st HKTDC Hong Kong International Jewellery Show and the 11th HKTDC Hong Kong International Diamond, Gem & Pea... ...
Built on standardized digital product catalogs, Catalog... at 01:05 Galderma's Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo ...
Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumours in particular can be difficult to treat surgically. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results